Recent studies have reported the involvement of RPN1 in pan-cancer (30), breast cancer (8, 31), and glioma (32); however, these studies do not provide a comprehensive analysis of the clinical and biological significance of RPN1 and its potential regulatory mechanisms across different cancers. Here, RPN1 is linked to breast carcinoma.